What is the recommended protocol for writing an Adderall (amphetamine and dextroamphetamine) IR prescription?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adderall IR Prescription Writing Protocol

When prescribing Adderall IR (immediate-release), start with a low dose of 5-10 mg once or twice daily and titrate weekly based on symptom response, with a maximum daily dose of 60 mg for most adults. 1

Initial Dosing and Titration

Starting Dose

  • For adults and adolescents: 10 mg once daily in the morning
  • For children (6+ years): 5 mg once or twice daily (morning and midday)
  • For small children (<45 lbs/20 kg): Use extra caution with lower starting doses 2

Titration Schedule

  1. Week 1: Starting dose (5-10 mg daily)
  2. Week 2: Increase by 5 mg increments if needed
  3. Week 3-4: Continue increasing by 5 mg weekly until optimal symptom control or maximum dose reached 2, 1

Dosing Frequency

  • Immediate-release formulation typically requires twice daily dosing
  • Standard administration: Morning dose after breakfast, second dose at midday/lunch
  • Consider adding a third afternoon dose to help with homework and evening activities 2

Prescription Writing Elements

Required Information

  • Patient's full name, address, and date of birth
  • Drug name: "Adderall" or "Mixed Amphetamine Salts"
  • Strength: Specify tablet strength (5 mg, 10 mg, 15 mg, 20 mg, or 30 mg)
  • Quantity: Calculate based on days of treatment (e.g., 60 tablets for 30 days at BID dosing)
  • Directions: "Take ___ mg by mouth ___ times daily" (specify exact timing if needed)
  • DEA number: Required as Adderall is a Schedule II controlled substance

Sample Prescription Format

Rx: Adderall (Mixed Amphetamine Salts) 10 mg tablets
Disp: #60 tablets
Sig: Take 1 tablet by mouth twice daily, morning and noon
No refills (Schedule II medication)

Monitoring and Follow-up

Initial Follow-up

  • Schedule follow-up within 1-2 weeks of starting medication
  • Assess vital signs (blood pressure, pulse) at each dose increase 2, 1
  • Document symptom response using standardized rating scales when possible

Ongoing Monitoring

  • Blood pressure and pulse at each visit
  • Height and weight periodically (especially in children)
  • Side effects assessment (appetite, sleep, irritability)
  • Efficacy assessment using standardized tools when available 1

Important Considerations

Maximum Dosing

  • Maximum daily dose: 60 mg for adults and children >6 years 2, 1
  • Some clinicians use weight-based dosing: up to 0.9 mg/kg for dextroamphetamine/amphetamine 1
  • When using higher doses, document clearly that symptoms could not be controlled at lower doses 2

Contraindications

  • Advanced arteriosclerosis
  • Symptomatic cardiovascular disease
  • Moderate to severe hypertension
  • Hyperthyroidism
  • Known hypersensitivity to amphetamine products
  • Glaucoma
  • Agitated states
  • History of drug abuse
  • During or within 14 days of MAO inhibitor use 2

Common Side Effects to Monitor

  • Decreased appetite
  • Insomnia
  • Headache
  • Stomach pain
  • Irritability
  • Increased heart rate and blood pressure 1, 3

Clinical Pearls

  • Adderall IR has been shown to be more potent on a milligram basis than methylphenidate IR, with 7.5 mg of Adderall producing effects comparable to 17.5 mg of methylphenidate 4
  • Consider timing the last daily dose to minimize sleep disruption
  • Document clearly if exceeding standard dosing ranges
  • For patients with anxiety disorders, be cautious as Adderall may precipitate anxiety symptoms 5
  • If a patient fails to respond to Adderall, consider switching to methylphenidate, as approximately 90% of patients will respond to either stimulant when both are tried 2

References

Guideline

ADHD Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adderall® (amphetamine-dextroamphetamine) toxicity.

Topics in companion animal medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.